Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Coman-Vlagea, Nicoleta, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2022